SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients

As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2, continues to spread rapidly around the world, there is a need for well validated serological assays that allow the detection of viral specific antibody responses in COVID-19 patients or recovered individuals. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Algaissi, Abdullah, Alfaleh, Mohamed A., Hala, Sharif, Abujamel, Turki S., Alamri, Sawsan S., Almahboub, Sarah A., Alluhaybi, Khalid A., Hobani, Haya I., Alsulaiman, Reem M., AlHarbi, Rahaf H., ElAssouli, M.-Z.aki, Alhabbab, Rowa Y., AlSaieedi, Ahdab A., Abdulaal, Wesam H., Al-Somali, Afrah A., Alofi, Fadwa S., Khogeer, Asim A., Alkayyal, Almohanad A., Mahmoud, Ahmad Bakur, Almontashiri, Naif A. M., Pain, Arnab, Hashem, Anwar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538990/
https://www.ncbi.nlm.nih.gov/pubmed/33024213
http://dx.doi.org/10.1038/s41598-020-73491-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538990/
https://www.ncbi.nlm.nih.gov/pubmed/33024213
http://dx.doi.org/10.1038/s41598-020-73491-5

Ejemplares similares